Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Novavax Inc (NASDAQ: NVAX)

$1.30 USD $0.01 (0.78%)
Last Price $1.3
Net Change $0.01 (0.78%)
Bid $1.3
Ask Price $1.31
Open Price $1.3
Previous Close Price $1.29
High Price $1.31
Low Price $1.26
Number of Trades 1,429
Volume 694,430
Fifty Two Week High $8.49 (2016-09-15)
Fifty Two Week Low $1.16 (2016-09-16)
Average Daily Volume 6,118,971
Share Outstanding 271,950 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.21 (2017-02-27)
2nd Quarter Earnings $-0.24 (2016-11-09)
3nd Quarter Earnings $-0.29 (2016-08-09)
4th Quarter Earnings $-0.29 (2016-05-04)
PE Ratio $0
EPS Growth $38.14
Recent Earnings $-0.21
Annual EPS $-1.03
Last Quarter EPS $
Market Capitalization $0.35B
Insider Shareholders % 0.035%
Annual Revenue $0B
No. Shares Outstanding 271,950
Inst. Shareholder % 53.65%
Annual Net Income $-0.28B
TTM Net Profit Margin $-1822.66
1-Year Return -75.24%
3-Year Return -71.52%
5-Year Return 2.38%
5-Year Revenue Growth 4.49%
5-Year Earnings Growth 442.11%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 38.139999%
Dividends per Share $
Stock Split Ratio
Beta 1.91
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary microscopic organized non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products including certain hormones anti-bacterial and anti-viral products and vaccine adjuvants.